We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Cross-Linked Implants Reduce Revision Surgery Rates

By HospiMedica International staff writers
Posted on 13 Aug 2018
Print article
Image: The Procotyl Prime acetabular XLPE cup system (Photo courtesy of MicroPort Orthopedics).
Image: The Procotyl Prime acetabular XLPE cup system (Photo courtesy of MicroPort Orthopedics).
A long-term follow-up study confirms that hip implants made of cross-linked polyethylene (XLPE) substantially lower the risk of revision surgery after total hip replacement.

Researchers at the South Australian Health and Medical Research Institute (SAHMRI; Adelaide, Australia) and the University of Adelaide (UA; Australia) conducted an observational study of all patients who underwent THA for osteoarthritis (OA) in Australia from 1999 through December 31, 2016, in order to compare total hip arthroplasty (THA) revision surgery rates between patients that received XLPE implants and those that received conventional non-cross-linked polyethylene (CPE) at 16 years follow up.

The data, extracted from the Australian Orthopaedic Association (Sydney, Australia) national joint replacement registry, revealed that CPE was used in 41,171 procedures, and XLPE was used in 199,131; men and women who received XLPE implants were slightly younger than those that underwent CPE. XLPE implants were associated with a lower rate of revision at six months, with the difference becoming more apparent over time. The 16-year cumulative percentage of revisions of primary THAs was 11.7% in the CPE group and 6.2% in the XLPE group.

After adjustment for other risk factors, patients with CPE implants were about three times more likely to have revision surgery after nine years, compared to those with XLPE implants. At seven years, younger patients with CPE hip prostheses were about five times more likely to need revision surgery. Revisions directly related to wear of the bearing surface occurred in 0.81% of procedures that used CPE, compared to just 0.05% of procedures that used XLPE. The study was published on August 1, 2018, in The Journal of Bone & Joint Surgery.

“Wear-related and implant-longevity issues are particularly important in younger patients, who are generally more active and have a longer life span than their older counterparts,” concluded Professor Richard de Steiger, MD, of SAHMRI, and colleagues. “We believe that the evidence of reduced long-term wear with XLPE is now so strong that, when a polyethylene bearing surface is used in THA, it should be XLPE, particularly in younger patients."

THA is one of the most effective surgical procedures for the management of hip OA. The most common bearing surface for THA has been conventional CPE, which has been in use for over 50 years. As limiting wear of the bearing surface is critical to long-term success, particularly for younger patients, research has led to the development of XLPE, which has improved wear characteristics.

Related Links:
South Australian Health and Medical Research Institute
University of Adelaide
Australian Orthopaedic Association

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Radial Shock Wave Device
MASTERPULS »ultra«

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.